These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9142431)

  • 21. Novel diazinone derivatives separate myofilament Ca2+ sensitization and phosphodiesterase III inhibitory effects in guinea pig myocardium.
    Ventura C; Miller R; Wolf HP; Beier N; Jonas R; Klockow M; Lues I; Hano O; Spurgeon HA; Lakatta EG
    Circ Res; 1992 Jun; 70(6):1081-90. PubMed ID: 1533576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive inotropic effects of the calcium channel activator Bay K 8644 on guinea-pig and human isolated myocardium.
    Näbauer M; Brown L; Erdmann E
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):85-92. PubMed ID: 2452989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New cardiotonic/inodilator agents: energetic aspects].
    Hasenfuss G
    Z Kardiol; 1992; 81 Suppl 4():57-63. PubMed ID: 1290307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart.
    Brunkhorst D; v der Leyen H; Meyer W; Nigbur R; Schmidt-Schumacher C; Scholz H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):575-83. PubMed ID: 2549430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation.
    Haikala H; Nissinen E; Etemadzadeh E; Levijoki J; Lindén IB
    J Cardiovasc Pharmacol; 1995 May; 25(5):794-801. PubMed ID: 7630157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of isomazole on force of contraction and phosphodiesterase isoenzymes I-IV in nonfailing and failing human hearts.
    Bethke T; Klimkiewicz A; Kohl C; von der Leyen H; Mehl H; Mende U; Meyer W; Neumann J; Schmitz W; Scholz H
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):386-97. PubMed ID: 1720839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new cardiotonic drug reduces the energy cost of active tension in cardiac muscle.
    Gross T; Lues I; Daut J
    J Mol Cell Cardiol; 1993 Mar; 25(3):239-44. PubMed ID: 8510167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of EMD 57033 on contraction and relaxation in isolated rabbit hearts.
    Hgashiyama A; Watkins MW; Chen Z; LeWinter MM
    Circulation; 1995 Nov; 92(10):3094-104. PubMed ID: 7586281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium.
    Hasenfuss G; Pieske B; Castell M; Kretschmann B; Maier LS; Just H
    Circulation; 1998 Nov; 98(20):2141-7. PubMed ID: 9815868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.
    Sato S; Talukder MA; Sugawara H; Sawada H; Endoh M
    J Mol Cell Cardiol; 1998 Jun; 30(6):1115-28. PubMed ID: 9689586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart.
    Orstavik O; Ata SH; Riise J; Dahl CP; Andersen GØ; Levy FO; Skomedal T; Osnes JB; Qvigstad E
    Br J Pharmacol; 2014 Dec; 171(23):5169-81. PubMed ID: 24547784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inotropic and chronotropic profile of MCI-154: comparison with isoproterenol and imazodan in guinea pig cardiac preparations.
    Allert JA; Adams HR
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):59-67. PubMed ID: 1696667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UD-CG 115--a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle.
    Honerjäger P; Heiss A; Schäfer-Korting M; Schönsteiner G; Reiter M
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):259-69. PubMed ID: 6328334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
    Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ
    Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative lusitropy and abnormal calcium handling in hypoxic cardiac myocytes exposed to the calcium-sensitizer EMD 53998.
    Webster KA; Bodi I; McNamara JP; Tracy M; Discher DJ; Bishopric NH
    J Mol Cell Cardiol; 1993 Jul; 25(7):747-51. PubMed ID: 8230239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of acidosis and hypoxia on the response of isolated ferret cardiac muscle to inotropic agents.
    Than N; Shah N; White J; Lee JA; Orchard CH
    Cardiovasc Res; 1994 Aug; 28(8):1209-17. PubMed ID: 7954624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of inotropic interventions on the force-frequency relation in the human heart.
    Bavendiek U; Brixius K; Münch G; Zobel C; Müller-Ehmsen J; Schwinger RH
    Basic Res Cardiol; 1998; 93 Suppl 1():76-85. PubMed ID: 9833134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiological actions of the pimobendan metabolite, UD-CG 212 Cl, in guinea pig myocardium.
    Westfall MV; Wahler GM; Fujino K; Solaro RJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):58-63. PubMed ID: 1346167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6-meth yl-3, 6-dihydro-2H-1,3,4-thiadiazin-2-one on skinned fibres and isolated ventricular strips.
    Herzig JW; Chiesi M; Depersin H; Grüninger S; Hasenfuss G; Kubalek R; Leutert T; Pieske B; Pioch K; Wenk P; Holubarsch C
    Arzneimittelforschung; 1996 Jun; 46(6):586-93. PubMed ID: 8767348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor.
    Wilhelm D; Wilffert B; Janssens WJ; Leidig A; Meuter C; Ebbert M; Peters T
    J Cardiovasc Pharmacol; 1992; 20(5):705-14. PubMed ID: 1280731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.